Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin

Neuroscience Letters

Volumn 349, Issue 3, 2003, Pages 191-195

  Hébert, Guillaume ^a   Arsaut, Josette ^a   Dantzer, Robert ^a   Demotes Mainard, Jacques ^a  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Matrix metalloproteinase; Mouse; Proinflammatory cytokines; Retrograde denervation; Striatal reorganization

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOKINE; DOPAMINE TRANSPORTER; GELATINASE A; GELATINASE B; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DOPAMINERGIC SYSTEM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MESENCEPHALON; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0142091435     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00832-2     Document Type: Article

References (20)

1. Bezard E., Dovero S., Imbert C., Boraud T., Gross C.E. Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse. 38:2000;363-368.
2. Bolin L.M., Strycharska-Orczyk I., Murray R., Langston J.W., Di Monte D. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J. Neurochem. 83:2002;167-175.
3. Cochiolo J.A., Ehsanian R., Bruck D.K. Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: evidence of compensatory plasticity in nigrostriatal neurons. J. Neurosci. Res. 59:2000;126-135.
4. Cuny E., Loiseau H., Penchet G., Ellie E., Arsaut J., Vital A., Vincendeau P., Demotes-Mainard J. Association of elevated glial expression of interleukin-1beta with improved survival in patients with glioblastomas multiforme. J. Neurosurg. 96:2002;294-301.
5. Esteve P.O., Tremblay P., Houde M., St-Pierre Y., Mandeville R. In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators. Biochim. Biophys. Acta. 1403:1998;85-96.
6. Finkelstein D.I., Stanic D., Parish C.L., Tomas D., Dickson K., Horne M.K. Axonal sprouting following lesions of the rat substantia nigra. Neuroscience. 97:2000;99-112.
7. Gottschall P.E., Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J. Neurochem. 64:1995;1513-1520.
8. Ho A., Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J. Neurosci. 18:1998;5614-5629.
9. Jackson-Lewis V., Jakowec M., Burke R.E., Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration. 4:1995;257-269.
10. Klevenyi P., Andreassen O., Ferrante R.J., Schleicher J.R. Jr., Friedlander R.M., Beal M.F. Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity. NeuroReport. 10:1999;635-638.
11. Konsman J.P., Kelley K., Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience. 89:1999;535-548.
12. Mennicken F., Savasta M., Peretti-Renucci R., Feuerstein C. Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935. J. Neural Transm. Gen. Sect. 87:1992;1-14.
13. Mitsumoto Y., Watanabe A., Mori A., Koga N. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice. Biochem. Biophys. Res. Commun. 248:1998;660-663.
14. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180:1994;147-150.
15. Mogi M., Togari A., Ogawa M., Ikeguchi K., Shizuma N., Fan D., Nakano I., Nagatsu T. Effects of repeated systemic administration of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum. Neurosci. Lett. 250:1998;25-28.
16. Parish C.L., Finkelstein D.I., Tripanichkul W., Satoskar A.R., Drago J., Horne M.K. The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. J. Neurosci. 22:2002;8034-8041.
17. Shu S.Y., Ju G., Fan L.Z. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 85:1988;169-171.
18. Song D.D., Haber S.N. Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J. Neurosci. 20:2000;5102-5114.
19. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 16:2002;1474-1476.
20. Wang J., Bankiewicz K.S., Plunkett R.J., Oldfield E.H. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain. J. Neurosurg. 80:1994;484-490.